Dulaglutide injection reduces risk of cardiovascular outcomes in type 2 diabetes mellitus by 12%

A weekly dulaglutide injection in addition to existing medication reduces the risk of cardiovascular outcomes in individuals with type 2 diabetes mellitus, compared with placebo, a study published in The Lancet has found.…